ZA200705034B - Peptides which mimic the antigenic regions of the hepatitis A virus - Google Patents

Peptides which mimic the antigenic regions of the hepatitis A virus

Info

Publication number
ZA200705034B
ZA200705034B ZA200705034A ZA200705034A ZA200705034B ZA 200705034 B ZA200705034 B ZA 200705034B ZA 200705034 A ZA200705034 A ZA 200705034A ZA 200705034 A ZA200705034 A ZA 200705034A ZA 200705034 B ZA200705034 B ZA 200705034B
Authority
ZA
South Africa
Prior art keywords
mimic
hepatitis
peptides
virus
antigenic regions
Prior art date
Application number
ZA200705034A
Other languages
English (en)
Inventor
Perez Hernandez Ela Maria
Martinez Casanueva Raiza
David I Stott
Talavera Coronel Arturo
Larralde Diaz Osmany
Camacho Casanova Frank
Amin Blanco Nevis
Sierra Gonzalez Gustavo
Original Assignee
Inst Finaly Ct De Produccion D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Finaly Ct De Produccion D filed Critical Inst Finaly Ct De Produccion D
Publication of ZA200705034B publication Critical patent/ZA200705034B/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5768—Hepatitis A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA200705034A 2004-12-06 2007-06-05 Peptides which mimic the antigenic regions of the hepatitis A virus ZA200705034B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20040270A CU23553A1 (es) 2004-12-06 2004-12-06 Péptidos que mimetizan las regiones antigénicas del virus de la hepatitis a

Publications (1)

Publication Number Publication Date
ZA200705034B true ZA200705034B (en) 2008-09-25

Family

ID=36577673

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200705034A ZA200705034B (en) 2004-12-06 2007-06-05 Peptides which mimic the antigenic regions of the hepatitis A virus

Country Status (6)

Country Link
EP (1) EP1832602A1 (es)
BR (1) BRPI0517139A (es)
CA (1) CA2623753A1 (es)
CU (1) CU23553A1 (es)
WO (1) WO2006060969A1 (es)
ZA (1) ZA200705034B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115537456A (zh) * 2022-08-01 2022-12-30 北京中医药大学 噬菌体展示介导的免疫多重定量pcr方法及其重组噬菌体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0705841A1 (en) * 1994-10-05 1996-04-10 SORIN BIOMEDICA S.p.A. Peptides havng antigenic activity against hepatitis A virus (HAV)
US7223535B2 (en) * 1996-04-19 2007-05-29 Centers For Disease Control Synthetic peptides immunoreactive with hepatitis A virus antibodies
ATE338061T1 (de) * 1999-07-15 2006-09-15 Us Gov Health & Human Serv Synthetische peptide die immunoreaktivität gegen den virus von hepatitis a zeigen

Also Published As

Publication number Publication date
BRPI0517139A (pt) 2008-09-30
WO2006060969A1 (es) 2006-06-15
EP1832602A1 (en) 2007-09-12
CU23553A1 (es) 2010-07-20
CA2623753A1 (en) 2006-06-15

Similar Documents

Publication Publication Date Title
EP1730167A4 (en) ACTIVE MACROCYCLIC PEPTIDES AGAINST HEPATITIS C VIRUS
GB0718984D0 (en) Structure of the hepatitis C virus NS5A protein
IL174403A0 (en) Macrocyclic peptides active against the hepatitis c virus
PL371007A1 (en) Macrocyclic peptides active against the hepatitis c virus
HK1138297A1 (en) Human antibodies against hepatitis c virus (hcv) uses thereof (hcv)
EP1773403A4 (en) VIRAL ADJUVANZIA
EP1684787A4 (en) INHIBITORS OF HEPATITIS C VIRUS
EP1684745A4 (en) INHIBITORS OF HEPATITIS C VIRUS
PL372937A1 (en) Viral antigens
GB0206359D0 (en) Viral antigens
EP1948229A4 (en) COMBINED VACCINE COMPRISING AN ATTENUATED VIRUS OF BOVINE VIRAL DIARRHEA
IL182083A0 (en) Recombinant newcastle disease virus
EP1763531A4 (en) ANALOGUE OF HEPATITIS-C INHIBITING PEPTIDES
ZA200804078B (en) Chimeric hepatitis C virus antigens for eliciting an immune response
EP1871411A4 (en) EXPRESSION OF HEPATITIS B VIRUS SURFACE ANTIGEN FOR VACCINE MANUFACTURE
EP1901537A4 (en) GENERAL INTELLECTUAL CLICK-TO-CHOOSE METHOD AND SOFTWARE STRUCTURE THEREFOR
EP1922084A4 (en) INFECTIOUS CLONES OF CHIKUNGUNYA VIRUSES AND USES THEREOF
HK1121698A1 (en) Marked bovine viral diarrhea virus vaccines
AU2003206862A1 (en) Hepatitis b vaccines
PL376967A1 (pl) Szczepionka przeciw HCV
HK1109069A1 (en) Vaccine composition against hepatitis c virus
EP1558628A4 (en) ANTIGENIC PEPTIDES
ZA200705034B (en) Peptides which mimic the antigenic regions of the hepatitis A virus
EP1945797A4 (en) Hepatitis C virus NS2 / 3 activity assay
AU2003256404A8 (en) Hepatitis c virus assays